Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis

Wide Cytokine Analysis in Cerebrospinal Fluid at Diagnosis Identified CCL-3 as a Possible Prognostic Factor for Multiple Sclerosis

(2020) Marco Puthenparampil et al.   Frontiers in Immunology

Multiplex assessment of cerebrospinal fluid biomarkers in multiple sclerosis

(2020) Mie Reith Mahler et al.   Multiple Sclerosis and Related Disorders

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

(2019) Ahmed Abdelhak et al.   Frontiers in Neurology

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis

(2019) Christiane Gasperi et al.   JAMA Neurology

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

(2019) Mitsuru Watanabe et al.   NEUROLOGY

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis

(2019) Sara Gil-Perotin et al.   Frontiers in Neurology

Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis

(2019) André Huss et al.   CLINICA CHIMICA ACTA

B cells in autoimmune and neurodegenerative central nervous system diseases

(2019) Joseph J. Sabatino et al.   NATURE REVIEWS NEUROSCIENCE

The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis

(2018) Sawsan Feki et al.   JOURNAL OF NEUROIMMUNOLOGY

The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis

(2018) Tilman Hottenrott et al.   JOURNAL OF NEUROLOGY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Shedding of BAFF/APRIL Receptors Controls B Cells

(2018) Edgar Meinl et al.   TRENDS IN IMMUNOLOGY

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration

(2018) Marc Pawlitzki et al.   Frontiers in Neurology

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein

(2017) Lenka Novakova et al.   NEUROLOGY

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

(2017) Xavier Montalban et al.   NEW ENGLAND JOURNAL OF MEDICINE

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics

(2017) Ahmed Abdelhak et al.   PLoS One

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle

(2017) Ahmed Abdelhak et al.   Frontiers in Neurology

YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis

(2016) Joachim Burman et al.   JOURNAL OF NEUROIMMUNOLOGY

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis

(2016) M.Alba Mañé-Martínez et al.   JOURNAL OF NEUROIMMUNOLOGY

The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature

(2016) S. Jarius et al.   JOURNAL OF NEUROLOGY

Neurofilament dynamics and involvement in neurological disorders

(2015) Benoit J. Gentil et al.   CELL AND TISSUE RESEARCH

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

γ-secretase directly sheds the survival receptor BCMA from plasma cells

(2015) Sarah A. Laurent et al.   Nature Communications

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

New Multiple Sclerosis Phenotypic Classification

(2014) Fred D. Lublin   EUROPEAN NEUROLOGY

The Immunoregulator Soluble TACI Is Released by ADAM10 and Reflects B Cell Activation in Autoimmunity

(2014) Franziska S. Hoffmann et al.   JOURNAL OF IMMUNOLOGY

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

(2012) Jack Antel et al.   ACTA NEUROPATHOLOGICA

Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse

(2012) Honghao Wang et al.   JOURNAL OF CLINICAL IMMUNOLOGY

CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation

(2012) Markus C Kowarik et al.   Journal of Neuroinflammation

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

B cells and antibodies in multiple sclerosis pathogenesis and therapy

(2012) Markus Krumbholz et al.   Nature Reviews Neurology

Intrathecal, Polyspecific Antiviral Immune Response in Oligoclonal Band Negative Multiple Sclerosis

(2012) Isabel Brecht et al.   PLoS One

Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis

(2011) Hayrettin Tumani et al.   ANNALS OF NEUROLOGY

Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid

(2011) Samia Ragheb et al.   Multiple Sclerosis Journal

Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course

(2010) Mohsen Khademi et al.   Multiple Sclerosis Journal

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking

(2009) C. E. Teunissen et al.   NEUROLOGY

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome

(2009) Johannes Brettschneider et al.   PLoS One